BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4113389)

  • 1. Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.
    Finkelstein JW; Kream J; Ludan A; Hellman L
    J Clin Endocrinol Metab; 1972 Jul; 35(1):13-7. PubMed ID: 4113389
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatomedin and the regulation of skeletal growth.
    Elders MJ; Wingfield BS; McNatt ML; Lee JA; Hughes ER
    Ann Clin Lab Sci; 1975; 5(6):440-51. PubMed ID: 1200618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of the diencephalic syndrome were reported with hormonal studies (author's transl)].
    Motomochi M; Makita Y; Nabeshima S; Itagaki T; Tei T; Keyaki A; Yoshimasa Y; Hamada S; Aoyama I
    No Shinkei Geka; 1981 Apr; 9(5):617-24. PubMed ID: 7242842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.
    New MI; Schwartz E; Parks GA; Landey S; Wiedemann E
    J Pediatr; 1972 Apr; 80(4):620-6. PubMed ID: 5015070
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth.
    Gluckman PD; Holdaway IM
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):545-9. PubMed ID: 991434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum somatomedin activity in children after surgery for craniopharyngioma (authors transl)].
    Martinez MJ; Chaussain JL; Schimpff RM; Donnadieu M; Roger M; Job JC
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():881-6. PubMed ID: 7332440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short stature and growth hormone].
    Okada Y; Hikita T; Ishitobi K; Harada Y
    Horumon To Rinsho; 1972 Apr; 20(4):285-90. PubMed ID: 4559326
    [No Abstract]   [Full Text] [Related]  

  • 8. Human somatomedin, the growth hormone dependent sulfation factor, is antilipolytic.
    Underwood LE; Hintz RL; Voina SJ; Van Wyk JJ
    J Clin Endocrinol Metab; 1972 Aug; 35(2):194-8. PubMed ID: 5072353
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of hGH treatment on somatomedin levels in the serum (as determined by 35-S uptake into cartilage).
    Schimpff RM; Donnadieu M; Gourmelen M; Girard F
    Horm Metab Res; 1974 Nov; 6(6):494-8. PubMed ID: 4476721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum prolactin, GH, TSH, LH, FSH in hypothalamo-pituitary diseases].
    Ogawa N; Yozai S; Miyoshi M; Takahara J; Ofuji T
    Horumon To Rinsho; 1975 Nov; 23(11):1133-7. PubMed ID: 1240031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption (author's transl)].
    Kerpel-Fronius E; Kiss S; Kardos G; Gács G
    Monatsschr Kinderheilkd (1902); 1977 Aug; 125(8):783-6. PubMed ID: 904638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
    Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP; Van Meter QL; Kowarski AA
    Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmatic growth hormone in hypothalamic tumors with cachexia (Russel's syndrome) and thinness].
    Jaquet P; Pierron H; Codaccioni JL
    Ann Pediatr (Paris); 1971 Jan; 18(1):73. PubMed ID: 5100931
    [No Abstract]   [Full Text] [Related]  

  • 15. Craniopharyngioma: the role of insulin in promoting postoperative growth.
    Costin G; Kogut MD; Phillips LS; Daughaday WH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma somatomedin activity measured as thymidine factor in normal children with average and constitutionally tall stature.
    Bozzola M; Schimpff RM; Thieriot-Prévost G; Leduc B; Job JC
    Horm Metab Res; 1982 Jul; 14(7):372-5. PubMed ID: 7118060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Somatomedin activity of the serum in the normal child and in hypopituitarism].
    Binet E; Schlumberger A; Chaussain JL; Job JC
    Arch Fr Pediatr; 1974 Apr; 31(4):339-46. PubMed ID: 4368260
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal growth with subnormal growth-hormone levels.
    Holmes LB; Frantz AG; Rabkin MT; Soeldner JS; Crawford JD
    N Engl J Med; 1968 Sep; 279(11):559-66. PubMed ID: 4299148
    [No Abstract]   [Full Text] [Related]  

  • 19. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum growth hormone levels in patients with brain tumors].
    Vinogradova IN; Pronina TS
    Vopr Neirokhir; 1967; 31(1):12-4. PubMed ID: 4297988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.